Results 211 to 220 of about 382,920 (355)

Central nervous system multiple myeloma – potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains [PDF]

open access: bronze, 2013
Denise Lee   +8 more
openalex   +1 more source

Exportin 1 Inhibitor Combined With Venetoclax Induces Apoptosis in Myelodysplastic Syndrome by Mitochondria‐Induced Apoptosis Pathway

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Inhibition of XPO1 is a promising modality in the treatment of MDS, especially when combined with Venetoclax, which activates mitochondria‐mediated apoptosis and could be a potential target for MDS therapy. ABSTRACT Background Myelodysplastic syndromes (MDS) are clonal hematopoietic malignancies that pose a serious health threat.
Xiaohan Liu   +8 more
wiley   +1 more source

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

open access: yesNew England Journal of Medicine, 2017
M. Mateos   +28 more
semanticscholar   +1 more source

Incidental discovery of acquired factor X deficiency in a patient with multiple myeloma. [PDF]

open access: yesLeuk Res Rep
Sbibih Y   +6 more
europepmc   +1 more source

Additional file 1: of Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma

open access: green, 2019
Maria CucĂ ̈   +18 more
openalex   +1 more source

Pseudohyperphosphatemia in Multiple Myeloma: A Systematic Review of Case Reports and Case Series

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Pseudohyperphosphatemia (PHP) is a clinically significant laboratory artifact in patients with multiple myeloma (MM). It is often caused by paraprotein interference with phosphate assays. This systematic review summarizes reported cases, underlying mechanisms, and diagnostic approaches to distinguish spurious from true hyperphosphatemia.
Mahsa Dabir   +3 more
wiley   +1 more source

Antitumor activity of thalidomide in refractory multiple myeloma.

open access: yesNew England Journal of Medicine, 1999
S. Singhal   +13 more
semanticscholar   +1 more source

The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma [PDF]

open access: bronze, 2017
Nicola Giuliani   +7 more
openalex   +1 more source

Tranexamic Acid in Lower Extremity Endoprosthetic Reconstruction for Oncologic Indications: A Retrospective Comparative Study of 617 Patients

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives While tranexamic acid (TXA) reduces blood loss in orthopedic surgery, thromboembolic concerns in cancer patients have limited adoption in orthopedic oncology. This study evaluated TXA efficacy and safety in patients undergoing endoprosthetic reconstruction for oncologic indications.
Stephen W. Chenard   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy